The emerging era of pharmacogenomics: current successes, future potential, and challenges
10.1111/cge.12392
Saved in:
Main Authors: | , , , , , , |
---|---|
Other Authors: | |
Format: | Review |
Language: | English |
Published: |
WILEY
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/235301 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
id |
sg-nus-scholar.10635-235301 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2353012024-04-17T09:53:27Z The emerging era of pharmacogenomics: current successes, future potential, and challenges Lee, JW Aminkeng, F Bhavsar, AP Shaw, K Carleton, BC Hayden, MR Ross, CJD MEDICINE Science & Technology Life Sciences & Biomedicine Genetics & Heredity ADRs adverse drug reactions anthracycline carbamazepine cisplatin codeine pharmacogenomics warfarin ANTHRACYCLINE-INDUCED CARDIOTOXICITY IMPLEMENTATION CONSORTIUM GUIDELINES WARFARIN DOSE REQUIREMENT ADVERSE DRUG-REACTIONS GENETIC POLYMORPHISMS HEARING-LOSS CHILDREN CODEINE CYP2C9 CHILDHOOD 10.1111/cge.12392 CLINICAL GENETICS 86 1 21-28 2022-12-05T02:16:57Z 2022-12-05T02:16:57Z 2014-07-01 2022-11-30T18:57:37Z Review Lee, JW, Aminkeng, F, Bhavsar, AP, Shaw, K, Carleton, BC, Hayden, MR, Ross, CJD (2014-07-01). The emerging era of pharmacogenomics: current successes, future potential, and challenges. CLINICAL GENETICS 86 (1) : 21-28. ScholarBank@NUS Repository. https://doi.org/10.1111/cge.12392 0009-9163 1399-0004 https://scholarbank.nus.edu.sg/handle/10635/235301 en WILEY Elements |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
language |
English |
topic |
Science & Technology Life Sciences & Biomedicine Genetics & Heredity ADRs adverse drug reactions anthracycline carbamazepine cisplatin codeine pharmacogenomics warfarin ANTHRACYCLINE-INDUCED CARDIOTOXICITY IMPLEMENTATION CONSORTIUM GUIDELINES WARFARIN DOSE REQUIREMENT ADVERSE DRUG-REACTIONS GENETIC POLYMORPHISMS HEARING-LOSS CHILDREN CODEINE CYP2C9 CHILDHOOD |
spellingShingle |
Science & Technology Life Sciences & Biomedicine Genetics & Heredity ADRs adverse drug reactions anthracycline carbamazepine cisplatin codeine pharmacogenomics warfarin ANTHRACYCLINE-INDUCED CARDIOTOXICITY IMPLEMENTATION CONSORTIUM GUIDELINES WARFARIN DOSE REQUIREMENT ADVERSE DRUG-REACTIONS GENETIC POLYMORPHISMS HEARING-LOSS CHILDREN CODEINE CYP2C9 CHILDHOOD Lee, JW Aminkeng, F Bhavsar, AP Shaw, K Carleton, BC Hayden, MR Ross, CJD The emerging era of pharmacogenomics: current successes, future potential, and challenges |
description |
10.1111/cge.12392 |
author2 |
MEDICINE |
author_facet |
MEDICINE Lee, JW Aminkeng, F Bhavsar, AP Shaw, K Carleton, BC Hayden, MR Ross, CJD |
format |
Review |
author |
Lee, JW Aminkeng, F Bhavsar, AP Shaw, K Carleton, BC Hayden, MR Ross, CJD |
author_sort |
Lee, JW |
title |
The emerging era of pharmacogenomics: current successes, future potential, and challenges |
title_short |
The emerging era of pharmacogenomics: current successes, future potential, and challenges |
title_full |
The emerging era of pharmacogenomics: current successes, future potential, and challenges |
title_fullStr |
The emerging era of pharmacogenomics: current successes, future potential, and challenges |
title_full_unstemmed |
The emerging era of pharmacogenomics: current successes, future potential, and challenges |
title_sort |
emerging era of pharmacogenomics: current successes, future potential, and challenges |
publisher |
WILEY |
publishDate |
2022 |
url |
https://scholarbank.nus.edu.sg/handle/10635/235301 |
_version_ |
1800915747184050176 |